Clinical Trials on Cell & Gene Therapy


Clinical Trials of Cell and Gene Therapy products often varying from the clinical trials design for other types of pharmaceutical products. This differences in trial design are necessitated by the distinctive features of these products. The clinical trials also reflect previous clinical experience and evidence of medicine. Early experiences with Cell and Gene Therapy products indicate that some CGT products may pose substantial risks to subjects due to effect at cellular and genetic level. The design of early-phase clinical trials of Cell and Gene Therapy products often involves the following consideration of clinical safety issues, preclinical issues, and chemistry, manufacturing and controls (CMC) issues that are encountered.


  • Gene Therapy Techniques
  • Gene Therapy Challenges

Related Conference of Clinical Trials on Cell & Gene Therapy

March 15-15, 2021

Genetics and Molecular biology

Paris, France
September 27-28, 2021

15th International Conference on Genomics & Pharmacogenomics

Vancouver, Canada
December 07-08, 2021

2nd World Congress on Cell and Structural Biology

Sydney, Australia
December 09-10, 2021

2nd International Conference on Geriatrics and Ageing

Sydney, Australia

Clinical Trials on Cell & Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in